Trimethoprim-sulfamethoxazole (TMP/SMX)
Trimethoprim-sulfamethoxazole (TMP/SMX) is a pharmaceutical drug with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 60.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
60.0%
3 of 5 finished
40.0%
2 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparative Efficacy of Antibiotics for Small Intestine Bacterial Overgrowth in Bangladeshi Children
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
Antibiotics for Kidney Transplant Recipients
Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)
Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV
Clinical Trials (7)
Comparative Efficacy of Antibiotics for Small Intestine Bacterial Overgrowth in Bangladeshi Children
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
Antibiotics for Kidney Transplant Recipients
Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)
Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV
Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection
DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7